Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis

Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis

Cytomegalovirus (CMV) is a common infection occurring in patients undergoing solid organ transplantation (SOT) or hematopoietic stem cell transplantation (HSCT). CMV-specific hyperimmunoglobulin (CMVIG) has been used for the past four decades and is typically administered either prophylactically or...

Full description

Bibliographic Details
Main Authors: Markus J. Barten, Fausto Baldanti, Alexander Staus, Christian M. Hüber, Kyriaki Glynou, Andreas Zuckermann
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Life
Subjects:
cytomegalovirus
CMV infection
human CMV hyperimmunoglobulin
CMVIG
prophylaxis
transplantation
Online Access:https://www.mdpi.com/2075-1729/12/3/361

Internet

https://www.mdpi.com/2075-1729/12/3/361

Similar Items